| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |